Literature DB >> 23879952

[Effects of noncoding RNA NRON gene regulation on human umbilical vein endothelial cells functions].

Yu-ye Tang1, Li-ke Wo, Hui Chai.   

Abstract

OBJECTIVE: To determine the effects of noncoding repressor of NFAT (NRON) overexpression or silencing on human umbilical vein endothelial cells (HUVECs) functions.
METHODS: Stable HUVECs cell lines with NRON overexpression and short hairpin RNA (shRNA) interference were obtained. HUVECs, the empty vector pBABE-cell line and the empty vector pSuper-cell line served as controls. Cell proliferations of these cell lines were tested using MTS method, tube formation capacity and migration function were also examined.
RESULTS: MTS experiments evidenced dose-dependent cells proliferations in all cell lines after 48 h culture with fetal bovine serum (HUVECs, r = 0.91;pBABE empty vectors cell-line, r = 0.88;NRON overexpression cell-line, r = 0.89;pSuper empty vectors cell-line, r = 0.95;shRNA infererence cell-line, r = 0.97). Proliferation capacity was lower in NRON overexpressed HUVECs and was higher in NRON silencing HUVECs compared with pBABE empty vectors treated and normal HUVECs (all P < 0.05). Tube formation and migration functions were also reduced in NRON overexpressed HUVECs [(8.33 ± 0.12) roots, (1857 ± 65) cells] and increased in shRNA infererence of NRON treated HUVECs [(36.00 ± 0.51) roots, (6987 ± 50) cells] compared with pBABE empty vectors treated HUVECs [(19.67 ± 1.42) roots, (4411 ± 117) cells], pSuper empty vectors treated HUVECs [(17.33 ± 2.93) roots, (3883 ± 109) cells] and normal HUVECs [(23.33 ± 3.01) roots, (5145 ± 72) cells, all P < 0.05].
CONCLUSION: NRON overexpression could reduce and NRON silencing could increase proliferation, tube formation and migration capacities of HUVECs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23879952

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN: 0253-3758


  8 in total

Review 1.  The short and long of noncoding sequences in the control of vascular cell phenotypes.

Authors:  Joseph M Miano; Xiaochun Long
Journal:  Cell Mol Life Sci       Date:  2015-05-29       Impact factor: 9.261

Review 2.  Long noncoding RNAs: emerging roles in pulmonary hypertension.

Authors:  Qi Jin; Zhihui Zhao; Qing Zhao; Xue Yu; Lu Yan; Yi Zhang; Qin Luo; Zhihong Liu
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

Review 3.  LncRNA as a Therapeutic Target for Angiogenesis.

Authors:  Mohan M Kumar; Ravi Goyal
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

Review 4.  Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease.

Authors:  Bo Yu; Shusheng Wang
Journal:  Theranostics       Date:  2018-06-08       Impact factor: 11.556

Review 5.  Multi-Omics Approaches to Study Long Non-coding RNA Function in Atherosclerosis.

Authors:  Adam W Turner; Doris Wong; Mohammad Daud Khan; Caitlin N Dreisbach; Meredith Palmore; Clint L Miller
Journal:  Front Cardiovasc Med       Date:  2019-02-19

6.  LncRNA Nron regulates osteoclastogenesis during orthodontic bone resorption.

Authors:  Ruilin Zhang; Junhui Li; Gongchen Li; Fujun Jin; Zuolin Wang; Rui Yue; Yibin Wang; Xiaogang Wang; Yao Sun
Journal:  Int J Oral Sci       Date:  2020-05-09       Impact factor: 6.344

Review 7.  Long Noncoding RNA: Recent Updates in Atherosclerosis.

Authors:  Hao Li; Hongming Zhu; Junbo Ge
Journal:  Int J Biol Sci       Date:  2016-06-07       Impact factor: 6.580

8.  LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer.

Authors:  Tiefu Xiong; Chenchen Huang; Jianfa Li; Shaokang Yu; Fangfang Chen; Zeng Zhang; Chengle Zhuang; Yawen Li; Changshui Zhuang; Xinbo Huang; Jing Ye; Fangting Zhang; Yaoting Gui
Journal:  J Cancer       Date:  2020-01-17       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.